Literature DB >> 239135

Metabolism of quinalbarbitone.

J N Gilbert, W L Hetherington, J W Powell, W B Whalley.   

Abstract

The human metabolism of (+/-)-5-allyl-5-(1'-methylbutyl) barbituric acid (I), quinalbarbitone, taken orally, has been studied. Comparison of g.c. and g.c.-m.s. data from derivatized extracts of urine with similar data from synthetic samples confirmed the presence of the two diastereoisomeric forms of 5-allyl-5-(3'hydroxy-1'-methylbutyl)barbituric acid (II), 5-allyl-5-(3'-oxo-1'-methylbutyl)barbituric acid (III), 5-allyl-5-(1'-methyl-3'-carboxypropyl)barbituric acid (IV), and 5-(2',3'-dihydroxypropyl)-5-(1'-methylbutyl)barbituric acid (V) in the urine. There was no evidence for the urinary excretion of unchanged drug. The rate of excretion of these metabolites has been examined in some detail, and rate-limited kinetics shown to apply for excretion of the acid (IV) and the diol (V).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239135     DOI: 10.1111/j.2042-7158.1975.tb09452.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Multidose studies in the human metabolism of pentobarbitone.

Authors:  W C Baldeo; J N Gilbert; J W Powell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

2.  Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network.

Authors:  Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2015-06-09       Impact factor: 14.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.